Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis. Mata DGMM, Sutradhar R, Castelo M, Hahn E, et al. Breast Cancer Res Treat 2025 Aug 13. doi: 10.1007/s10549-025-07778.

Read + Share

Amedeo Smart

Independent Medical Education

Mata DGMM, Sutradhar R, Castelo M, Hahn E, et al. Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis. Breast Cancer Res Treat 2025 Aug 13. doi: 10.1007/s10549-025-07778.
PMID: 40801982